Delirium and COVID-19
Older adult COVID-19 patients are at a high risk for delirium, and delirium or altered mental status can be a presenting symptom for COVID-19. The Hospital Elder Life Program has created a resource page for delirium and COVID-19, including a "HELP Toolkit" to help older adult patients maintain physical and cognitive functioning while isolated in the hospital.
The Delirium Bibliography
A searchable library of over 3,000 references on delirium and acute care for older adults, now available on the NIDUS site!
Spread the word about NIDUS!
Delirium Research Hub: Now Live
Submit your study through the submission portal for inclusion!
Have you used the Delirium Research Hub? Now that it has hundreds of delirium studies listed, we'd like to hear your story about how the Hub has been useful to you. Please email us your story about how the Hub has helped you. Check back because you and your research might be featured on the NIDUS website!
Welcome to NIDUS
Network for Investigation of Delirium: Unifying Scientists
The NIDUS Blog features interesting posts on delirium research, prevention and treatments
NIDUS is a collaborative, multidisciplinary network dedicated to the acceleration of scientific discovery in delirium research, through focused collaboration and creation of sustainable infrastructure to enhance innovative and high-quality research.
NIDUS was created in response to a call from the National Institutes on Aging to support a collaborative network to advance scientific research on the causes, mechanisms, outcomes, diagnosis, prevention, and treatment of delirium in older adults.
Greetings from Dr. Sharon Inouye!
Delirium Research Hub by the Numbers
Contributed by Zoë Tieges, PhD, Psychology Research Fellow, Geriatric Medicine, Usher Institute, The University of Edinburgh Severity grading of delirium in research and clinical practice may have important value in monitoring clinical course and recovery, in providing prognostic information for risk stratification, in informing treatment, and as endpoints in clinical trials. Fine-grained measures of delirium […]
Contributed by Benjamin K. I. Helfand, MSc, MD/PhD (candidate), University of Massachusetts Medical School Delirium affects approximately 3 million older Americans annually, accounting for over $164 billion in healthcare expenditures.1 Delirium disproportionately affects our older population (over age 65) with major public health implications. Development of delirium is associated with prolonged hospitalization, cognitive decline, and […]